Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Expression analysis of human uPAR on HEK293/Human uPAR Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human uPAR Stable Cell Line or negative control cell using PE-labeled anti-human uPAR antibody.
Expression analysis of human uPAR on CHO/Human uPAR Stable Cell Line by FACS.
Cell surface staining was performed on CHO/Human uPAR Stable Cell Line or negative control cell using PE-labeled anti-human uPAR antibody.
Human PLAU, His Tag (Cat. No. PLU-H5229) capture on NTA-Series S sensor chip can bind Mouse uPAR Protein, Fc Tag (Cat. No. UPR-M5253) with an affinity constant of 182 nM as determined in a SPR assay (Biacore 8K) (QC tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Gallium-68 NOTA AE105 (Curasight) | CS-001; 68Ga-NOTA-AE105 | Phase 3 Clinical | Rigshospitalet, Curasight Aps | Head and Neck Neoplasms; Bone metastases; Neoplasms; Glioblastoma; Neuroendocrine Tumors; Urinary Bladder Neoplasms; Mesothelioma; Breast Neoplasms; Prostatic Neoplasms; Oropharyngeal Neoplasms; Genital Neoplasms, Female; Mouth Neoplasms; Hair Diseases; Carcinoma, Non-Small-Cell Lung | Details |
| WAL0921 | WAL0921; WAL-0921; WAL 0921 | Phase 2 Clinical | Walden Biosciences Inc | Glomerulonephritis, IGA; Kidney Diseases; Nephrosis, Lipoid; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Diabetic Nephropathies; Renal Insufficiency, Chronic | Details |
| 64Cu-DOTA-AE105 | 64Cu-DOTA-AE105 | Phase 2 Clinical | Rigshospitalet | Urinary Bladder Neoplasms; Prostatic Neoplasms; Breast Neoplasms | Details |
| FG-001 | FG001; FG-001 | Phase 2 Clinical | FluoGuide AS | Head and Neck Neoplasms; Brain Neoplasms; Glioma; Lung Neoplasms; Meningioma | Details |
| MNPR-101-Lu177 | MNPR-101-Lu177; MNPR-101-PCTA-177Lu | Phase 1 Clinical | Monopar Therapeutics Inc | Solid tumours; Ovarian Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Colorectal Neoplasms; Lung Neoplasms | Details |
| MNPR-101-Zr | MNPR-101-Zr; MNPR-101-DFO*-89Zr | Phase 1 Clinical | Monopar Therapeutics Inc, Northstar Medical Radioisotopes Llc | Solid tumours; Ovarian Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Triple Negative Breast Neoplasms; Neoplasms; Urinary Bladder Neoplasms; Colorectal Neoplasms; Lung Neoplasms | Details |
| KMHH-03 | KMHH-03; KMHH03 | Phase 1 Clinical | Beijing Kangming Haihui Biological Technology Co Ltd | Breast Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
